Moxetumomab Pasudotox-tdfk and Sinemet CR 200/50
Determining the interaction of Moxetumomab Pasudotox-tdfk and Sinemet CR 200/50 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Sinequan
- Moxetumomab Pasudotox-tdfk-Sinequan (Doxepin Capsules)
- Moxetumomab Pasudotox-tdfk-Sinequan (Doxepin Oral Concentrate)
- Moxetumomab Pasudotox-tdfk-Sinex Long-Acting
- Moxetumomab Pasudotox-tdfk-Sinex Nasal Spray
- Moxetumomab Pasudotox-tdfk-Singulair
- Sinemet CR 200/50-Moxetumomab pasudotox-tdfk Intravenous
- Sinemet CR 200/50-Moxifloxacin
- Sinemet CR 200/50-Moxifloxacin (Systemic)
- Sinemet CR 200/50-Moxifloxacin Hydrochloride
- Sinemet CR 200/50-Moxifloxacin Injection
- Sinemet CR 200/50-Moxifloxacin Intravenous